Vision ageing
Human evidence and active trials are visible in this field
1,001 human-evidence records · 261 active trials · 147 visible funding records · 6,125 universities
Australian Patent Application
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
Source-linked patent metadata for Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF, including priority, record stage and longevity-topic connections.
Australian application snapshot
Patent application record
This privacy-minimal view describes one official Australian patent application record. It is not presented as a complete worldwide patent family.
- Application number
- AU2026204050
- Earliest priority
- December 3, 2015
- Application date
- May 26, 2026
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Vision ageing82% metadata match
How the patent office classifies this invention
C12Q1/68
Verify in the original patent source →